Acute effects of vecuronium on pulmonary function and hypoxemic episodes in preterm infants

Cynthia (Cindy) McEvoy, Smeeta Sardesai, Diane Schilling, Manuel Durand

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: Varying effects of pancuronium on neonatal pulmonary mechanics have been documented, including a decrease in pulmonary compliance or no significant change in compliance; but measurements of respiratory mechanics or quantification of episodes of hypoxemia in preterm newborns receiving vecuronium (Norcuron, Bedford Labs, Bedford, OH, USA) have not been reported. The objective of the present study was to quantify the short-term effects of vecuronium on pulmonary mechanics and episodes of hypoxemia in preterm infants receiving mechanical ventilation. Methods: A total of 15 preterm infants (birthweight 610-1560 g, gestational age 25-32 weeks, postnatal age 0.2-22 days) was studied. The initial dose of vecuronium used for the study was 0.2 mg/kg i.v. Measurements of respiratory mechanics were obtained 1 h prior to and 1 h after the initial dose of vecuronium at comparable ventilator settings and fractional inspired oxygen concentration (FiO2). Dynamic respiratory compliance and respiratory resistance were calculated by two-factor least mean square analysis. Pulse oximeter oxygen saturation (SpO2) was measured during both 1 h intervals with the Nellcor N-200 oximeter, a computer, and a software program for quantification of episodes of hypoxemia. Heart rate and blood pressure were also monitored. Results: There were no significant differences in tidal volume, respiratory compliance, or respiratory resistance when comparing measurements obtained before and after vecuronium administration. However, fewer episodes of hypoxemia (SpO2 <85%, P = 0.025; and SpO2 <80%, P = 0.04) were observed during muscle relaxation. No significant changes in heart rate or blood pressure were noted. Conclusions: The preliminary data indicate: (i) a single dose of vecuronium does not significantly change respiratory compliance or respiratory resistance in preterm infants and (ii) during muscle relaxation fewer episodes of desaturation (hypoxemia) are observed.

Original languageEnglish (US)
Pages (from-to)631-636
Number of pages6
JournalPediatrics International
Volume49
Issue number5
DOIs
StatePublished - Oct 2007

Fingerprint

Vecuronium Bromide
Premature Infants
Lung
Compliance
Respiratory Mechanics
Muscle Relaxation
Mechanics
Heart Rate
Oxygen
Blood Pressure
Lung Compliance
Pancuronium
Tidal Volume
Mechanical Ventilators
Least-Squares Analysis
Artificial Respiration
Gestational Age
Software
Hypoxia
Newborn Infant

Keywords

  • Hypoxemia
  • Muscle relaxants
  • Premature infants
  • Pulmonary mechanics
  • Vecuronium

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Acute effects of vecuronium on pulmonary function and hypoxemic episodes in preterm infants. / McEvoy, Cynthia (Cindy); Sardesai, Smeeta; Schilling, Diane; Durand, Manuel.

In: Pediatrics International, Vol. 49, No. 5, 10.2007, p. 631-636.

Research output: Contribution to journalArticle

McEvoy, Cynthia (Cindy) ; Sardesai, Smeeta ; Schilling, Diane ; Durand, Manuel. / Acute effects of vecuronium on pulmonary function and hypoxemic episodes in preterm infants. In: Pediatrics International. 2007 ; Vol. 49, No. 5. pp. 631-636.
@article{ba487a39acca4126aba1413360574138,
title = "Acute effects of vecuronium on pulmonary function and hypoxemic episodes in preterm infants",
abstract = "Background: Varying effects of pancuronium on neonatal pulmonary mechanics have been documented, including a decrease in pulmonary compliance or no significant change in compliance; but measurements of respiratory mechanics or quantification of episodes of hypoxemia in preterm newborns receiving vecuronium (Norcuron, Bedford Labs, Bedford, OH, USA) have not been reported. The objective of the present study was to quantify the short-term effects of vecuronium on pulmonary mechanics and episodes of hypoxemia in preterm infants receiving mechanical ventilation. Methods: A total of 15 preterm infants (birthweight 610-1560 g, gestational age 25-32 weeks, postnatal age 0.2-22 days) was studied. The initial dose of vecuronium used for the study was 0.2 mg/kg i.v. Measurements of respiratory mechanics were obtained 1 h prior to and 1 h after the initial dose of vecuronium at comparable ventilator settings and fractional inspired oxygen concentration (FiO2). Dynamic respiratory compliance and respiratory resistance were calculated by two-factor least mean square analysis. Pulse oximeter oxygen saturation (SpO2) was measured during both 1 h intervals with the Nellcor N-200 oximeter, a computer, and a software program for quantification of episodes of hypoxemia. Heart rate and blood pressure were also monitored. Results: There were no significant differences in tidal volume, respiratory compliance, or respiratory resistance when comparing measurements obtained before and after vecuronium administration. However, fewer episodes of hypoxemia (SpO2 <85{\%}, P = 0.025; and SpO2 <80{\%}, P = 0.04) were observed during muscle relaxation. No significant changes in heart rate or blood pressure were noted. Conclusions: The preliminary data indicate: (i) a single dose of vecuronium does not significantly change respiratory compliance or respiratory resistance in preterm infants and (ii) during muscle relaxation fewer episodes of desaturation (hypoxemia) are observed.",
keywords = "Hypoxemia, Muscle relaxants, Premature infants, Pulmonary mechanics, Vecuronium",
author = "McEvoy, {Cynthia (Cindy)} and Smeeta Sardesai and Diane Schilling and Manuel Durand",
year = "2007",
month = "10",
doi = "10.1111/j.1442-200X.2007.02405.x",
language = "English (US)",
volume = "49",
pages = "631--636",
journal = "Pediatrics International",
issn = "1328-8067",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Acute effects of vecuronium on pulmonary function and hypoxemic episodes in preterm infants

AU - McEvoy, Cynthia (Cindy)

AU - Sardesai, Smeeta

AU - Schilling, Diane

AU - Durand, Manuel

PY - 2007/10

Y1 - 2007/10

N2 - Background: Varying effects of pancuronium on neonatal pulmonary mechanics have been documented, including a decrease in pulmonary compliance or no significant change in compliance; but measurements of respiratory mechanics or quantification of episodes of hypoxemia in preterm newborns receiving vecuronium (Norcuron, Bedford Labs, Bedford, OH, USA) have not been reported. The objective of the present study was to quantify the short-term effects of vecuronium on pulmonary mechanics and episodes of hypoxemia in preterm infants receiving mechanical ventilation. Methods: A total of 15 preterm infants (birthweight 610-1560 g, gestational age 25-32 weeks, postnatal age 0.2-22 days) was studied. The initial dose of vecuronium used for the study was 0.2 mg/kg i.v. Measurements of respiratory mechanics were obtained 1 h prior to and 1 h after the initial dose of vecuronium at comparable ventilator settings and fractional inspired oxygen concentration (FiO2). Dynamic respiratory compliance and respiratory resistance were calculated by two-factor least mean square analysis. Pulse oximeter oxygen saturation (SpO2) was measured during both 1 h intervals with the Nellcor N-200 oximeter, a computer, and a software program for quantification of episodes of hypoxemia. Heart rate and blood pressure were also monitored. Results: There were no significant differences in tidal volume, respiratory compliance, or respiratory resistance when comparing measurements obtained before and after vecuronium administration. However, fewer episodes of hypoxemia (SpO2 <85%, P = 0.025; and SpO2 <80%, P = 0.04) were observed during muscle relaxation. No significant changes in heart rate or blood pressure were noted. Conclusions: The preliminary data indicate: (i) a single dose of vecuronium does not significantly change respiratory compliance or respiratory resistance in preterm infants and (ii) during muscle relaxation fewer episodes of desaturation (hypoxemia) are observed.

AB - Background: Varying effects of pancuronium on neonatal pulmonary mechanics have been documented, including a decrease in pulmonary compliance or no significant change in compliance; but measurements of respiratory mechanics or quantification of episodes of hypoxemia in preterm newborns receiving vecuronium (Norcuron, Bedford Labs, Bedford, OH, USA) have not been reported. The objective of the present study was to quantify the short-term effects of vecuronium on pulmonary mechanics and episodes of hypoxemia in preterm infants receiving mechanical ventilation. Methods: A total of 15 preterm infants (birthweight 610-1560 g, gestational age 25-32 weeks, postnatal age 0.2-22 days) was studied. The initial dose of vecuronium used for the study was 0.2 mg/kg i.v. Measurements of respiratory mechanics were obtained 1 h prior to and 1 h after the initial dose of vecuronium at comparable ventilator settings and fractional inspired oxygen concentration (FiO2). Dynamic respiratory compliance and respiratory resistance were calculated by two-factor least mean square analysis. Pulse oximeter oxygen saturation (SpO2) was measured during both 1 h intervals with the Nellcor N-200 oximeter, a computer, and a software program for quantification of episodes of hypoxemia. Heart rate and blood pressure were also monitored. Results: There were no significant differences in tidal volume, respiratory compliance, or respiratory resistance when comparing measurements obtained before and after vecuronium administration. However, fewer episodes of hypoxemia (SpO2 <85%, P = 0.025; and SpO2 <80%, P = 0.04) were observed during muscle relaxation. No significant changes in heart rate or blood pressure were noted. Conclusions: The preliminary data indicate: (i) a single dose of vecuronium does not significantly change respiratory compliance or respiratory resistance in preterm infants and (ii) during muscle relaxation fewer episodes of desaturation (hypoxemia) are observed.

KW - Hypoxemia

KW - Muscle relaxants

KW - Premature infants

KW - Pulmonary mechanics

KW - Vecuronium

UR - http://www.scopus.com/inward/record.url?scp=34548687945&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548687945&partnerID=8YFLogxK

U2 - 10.1111/j.1442-200X.2007.02405.x

DO - 10.1111/j.1442-200X.2007.02405.x

M3 - Article

C2 - 17875090

AN - SCOPUS:34548687945

VL - 49

SP - 631

EP - 636

JO - Pediatrics International

JF - Pediatrics International

SN - 1328-8067

IS - 5

ER -